文献速递白血病

急性髓系白血病靶向治疗遗传靶点的鉴定

Identification of genetic targets in acute myeloid leukaemia for designing targeted therapy.
PubMed 文献 · Br J Haematol · 2020-10-06

结论认为NOX家族基因是AML治疗开发的有吸引力的候选靶点。

要点

  • NOX1在6例AML患者中2例排名第一,另4例中3例显示高效。
  • NOX2同样具有明确敲低效力,NOX家族为潜在治疗靶点。

核心结论

  • NOX家族基因是AML治疗开发的有吸引力的候选靶点。

研究设计与样本

  • 采用多时间点评估等方法确保基因敲低均衡。

主要发现

  • NOX1影响白血病细胞生存,在6例患者中2例排名第一,另4例中3例显示高效。
  • NOX2是NOX家族中具有明确敲低效力的成员。

局限性

  • 原代细胞筛选困难,既往多数研究在细胞系中进行NGS文库敲低筛选。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Few effective therapies exist for acute myeloid leukaemia (AML), in part due to the molecular heterogeneity of this disease. We sought to identify genes crucial to deregulated AML signal transduction pathways which, if inhibited, could effectively eradicate leukaemia stem cells. Due to difficulties in screening primary cells, most previous studies have performed next-generation sequencing (NGS) library knockdown screens in cell lines. Using carefully considered methods including evaluation at multiple timepoints to ensure equitable gene knockdown, we employed a large NGS short hairpin RNA (shRNA) knockdown screen of nearly 5 000 genes in primary AML cells from six patients to identify genes that are crucial for leukaemic survival. Across various levels of stringency, genome-wide bioinformatic analysis identified a gene in the NOX family, NOX1, to have the most consistent knockdown effectiveness in primary cells (P = 5∙39 × 10-5 , Bonferroni-adjusted), impacting leukaemia cell survival as the top-ranked gene for two of the six AML patients and also showing high effectiveness in three of the other four patients. Further investigation of this pathway highlighted NOX2 as the member of the NOX family with clear knockdown efficacy. We conclude that genes in the NOX family are enticing candidates for therapeutic development in AML.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Mason CC, Fiol CR, Baker MJ, et al. Identification of genetic targets in acute myeloid leukaemia for designing targeted therapy. Br J Haematol. 2020. PMID: 33022753. doi:10.1111/bjh.17129

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。